Clinical Trial Update: Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study) [Phase 3]

View source ↗

Summary

The CARBOGEN Phase 3 trial comparing CO2 and phenylephrine for progressive lacunar infarction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lacunar Infarction
• Stroke

Drugs mentioned

• CARBON DIOXIDE (CARBON DIOXIDE)
• Phenylephrine (phenylephrine)

Snippet

Sponsor: Yonsei University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: TERMINATED